Related Experiment Videos

Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile

Xuefeng B Ling1, Claudia Macaubas, Heather C Alexander

  • 1Program in Immunology, Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.

BMC Medicine
|October 25, 2012
PubMed

Insights

Gene expression in systemic juvenile idiopathic arthritis (SJIA) reveals distinct inflammatory pathways compared to polyarticular JIA (POLY). SJIA pathways link systemic and arthritic components, differing between early and late disease stages.

Area of Science:

  • Immunology
  • Genetics
  • Pediatric Rheumatology

Background:

  • Systemic juvenile idiopathic arthritis (SJIA) and polyarticular JIA (POLY) exhibit distinct clinical phenotypes.
  • Investigating gene expression in peripheral blood mononuclear cells (PBMC) can elucidate disease-specific biological pathways.
  • Hypothesis: Gene expression profiles will reveal distinct pathways associated with disease activity markers (ESR, JC) in SJIA and POLY.

Purpose of the Study:

  • To identify distinct gene expression profiles and associated biological pathways in SJIA versus POLY.
  • To correlate gene expression with markers of disease activity: erythrocyte sedimentation rate (ESR) and joint count (JC).
  • To explore differences in immunobiology between early and late stages of SJIA.

Main Methods:

  • PBMC RNA from SJIA and POLY patients was analyzed using kinetic PCR for 181 immune response genes.
  • Pearson correlation and Student's t-test identified transcripts significantly associated with ESR and JC.
  • Ingenuity Systems Pathways Analysis was used to determine biological pathways linked to identified transcripts.

Main Results:

  • SJIA showed 91 ESR-related and 92 JC-related genes; POLY showed 20 ESR-related and 0 JC-related genes.
  • Pathways associated with ESR and JC in SJIA were strongly correlated, unlike SJIA and POLY ESR-related pathways.
  • Distinct pathways correlated with JC in early (SAF) versus late (AF) SJIA, with IL-10 linked to JC in SAF and lack of IL-4 in AF.

Conclusions:

  • The strong correlation between ESR and JC pathways in SJIA suggests mechanistic links between systemic and arthritic components.
  • Inflammatory pathways in SJIA are distinct from POLY, aligning with observed target organ differences.
  • Distinct pathways in early and late SJIA suggest evolving immunobiology underlies arthritis progression.
Abstract

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...